Financing › Details

BSSN Software–Merck (DE): investment, 201908 acquisition €na of BSSN Software GmbH by Merck KGaA

 

Period Period 2019-08-06
  Predecessor Merck (DE)–BSSN Software: laboratory software, 2014– supply Merck working with BSSN Software
Organisations Money taker BSSN Software GmbH
  Group Merck (DE) (Group)
  Money source Merck KGaA
  Group Merck (DE) (Group)
Products Product LIMS (laboratory information management system)
  Product 2 electronic laboratory notebook (ELN) (software)
     

Merck KGaA. (8/6/19). "Press Release: Merck Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab". Darmstadt.

> Gives scientists better, more efficient access to their lab data

> Boosts Merck’s digital laboratory productivity business, commercial growth


Merck, a leading science and technology company, has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and long-term archiving. Financial details were not disclosed.

“BSSN Software and the capabilities that it brings will allow Merck’s customers to better use and share their scientific data — the most important part of laboratory experiments,” said Jean-Charles Wirth, head of Applied Solutions at the Life Science business sector of Merck. “We acquired this company for commercial growth of the lab data management technology that BSSN provided for many years. This acquisition creates opportunity and gives Merck a unique position in this fast-paced market.”

BSSN Software is known for developing and marketing data management and integration software that unifies data from instruments and data systems and makes them available for analyzing, processing and sharing. It collects and converts scientific data from a broad range of more than 200 lab instrument models into a single, unified format. As a middleware offering, it facilitates communication and data flow between instruments and systems, such as laboratory information management systems, electronic lab notebooks and enterprise resource planning systems. The acquisition complements Merck’s efforts to support its customers’ digital transformation in the lab.

Since 2014, Merck has been working with BSSN Software, which primarily served pharmaceutical and food and beverage customers and provided services to facilitate standard laboratory efforts. BSSN Software was the first company to introduce to the market a complete AnIML implementation, an open standardized XML data format for storing and sharing of experiment data. With this acquisition, Merck is combining BSSN’s technology with its market access and laboratory domain knowledge to develop and commercialize an open and interoperable platform for laboratory data.

Merck is committed to the continued development and support of the current BSSN Software product portfolio, its customers and partnerships, as well as an open ecosystem building on the AnIML standard and Standardization in Lab Automation.

BSSN’s employees have joined Merck as part of its Applied Digital Lab Productivity Solutions team.


For more information, please contact
Karen Tiano
+49 6151 72 44461
Email

Follow Merck on Twitter @Merckgroup, on Facebook @merckgroup and on LinkedIn.

All Merck news releases are distributed by email at the same time they become available on the Merck website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


About Merck

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene- editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – Merck is everywhere. In 2018, Merck generated sales of €14.8 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the “Merck” name and brand. The only exceptions are the United States and Canada, where the business sectors operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.

   
Record changed: 2019-08-08

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px




» top